Business Insider16h
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024 ... scientist at the University Hospital of Dusseldorf in Germany and ...
Business Insider17h
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Collaborations: Mersana continues to advance its Johnson & Johnson and Merck KGaA, Darmstadt, Germany collaborations. The collaboration with Merck KGaA, Darmstadt, Germany focuses on discovering novel ...
PR Newswire1h
75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight
Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain ...
PR Newswire8h
Genomics Market to Hit USD 66.85 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™
Based on offerings, the genomics market is divided into product and service segments. The product segment accounted for the ...
Finanznachrichten43m
DelveInsight Business Research, LLP: 75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight
Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...